SevenBridge Financial Group, LLC

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-25,000	-100%	$0.54	Q4 2025
30 Sep 2025	0%	0%	$19,333	25,000	0		$0.77	Q3 2025
30 Jun 2025	0%	-0%	$17,500	25,000	-21,000	-46%	$0.70	Q2 2025
31 Mar 2025	0.01%	0%	$33,626	46,000	0		$0.73	Q1 2025
31 Dec 2024		0%	$26,937	41,000	0		$0.66 ^*	Q4 2024
30 Sep 2024		0%	$44,690	41,000	0		$1.09 ^*	Q3 2024
30 Jun 2024	0.01%	+0%	$37,179	41,000	+10,000	+32%	$0.91	Q2 2024
31 Mar 2024	0.01%	+0.01%	$36,580	31,000	+31,000	NEW	$1.18	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.